Effects of Extracorporeal Membrane Oxygenation Initiation on Oxygenation and Pulmonary Opacities

1Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organisation Registry International Report 2016. ASAIO J. 2017;63:60‐7. Thiagarajan RR Barbaro RP Rycus PT et al Extracorporeal Life Support Organisation Registry International Report 2016 ASAIO J 20176360‐710.1097/MAT.000000000000047527984321Search in Google Scholar

2Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20:387. Millar JE Fanning JP McDonald CI McAuley DF Fraser JF The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology Crit Care 20162038710.1186/s13054-016-1570-4512504327890016Search in Google Scholar

3Wang S, Krawiec C, Patel S, et al. Laboratory evaluation of hemolysis and systemic inflammatory response in neonatal non-pulsatile and pulsatile extracorporeal life support systems. Artif Organs. 2015;39:774-81. Wang S Krawiec C Patel S et al Laboratory evaluation of hemolysis and systemic inflammatory response in neonatal non-pulsatile and pulsatile extracorporeal life support systems Artif Organs 201539774 8110.1111/aor.1246625940752Search in Google Scholar

4Rungatscher A, Tessari M, Stranieri C, et al. Oxygenator is the main responsible for leukocyte activation in an experimental model of extracorporeal circulation: a cautionary tale. Mediators Inflamm. 2015;2015:484979. Rungatscher A Tessari M Stranieri C et al Oxygenator is the main responsible for leukocyte activation in an experimental model of extracorporeal circulation: a cautionary tale Mediators Inflamm 2015201548497910.1155/2015/484979443420226063972Search in Google Scholar

5McILwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest. 2010;90:128-39. McILwain RB Timpa JG Kurundkar AR et al Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine Lab Invest 201090128 3910.1038/labinvest.2009.119279954919901912Search in Google Scholar

6Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate. 2005;88:321-7. Mildner RJ Taub N Vyas JR et al Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure Biol Neonate 200588321 710.1159/00008763016113527Search in Google Scholar

7Graulich J, Sonntag J, Marcinkowski M, et al. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. 2002;11:69-73. Graulich J Sonntag J Marcinkowski M et al Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation Mediators Inflamm 20021169 7310.1080/09629350220131908178164812061426Search in Google Scholar

8Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352.. Doyle AJ Hunt BJ Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components Front Med (Lausanne) 2018535210.3389/fmed.2018.00352629900930619862Search in Google Scholar

9Sniderman J, Monagle P, Annich GM, MacLaren G. Hematologic concerns in extracorporeal membrane oxygenation. Res Pract Thromb Haemost. 2020;4:455-468. Sniderman J Monagle P Annich GM MacLaren G Hematologic concerns in extracorporeal membrane oxygenation Res Pract Thromb Haemost 20204455 46810.1002/rth2.12346729266932548547Search in Google Scholar

10Graulich J, Walzog B, Marcinkowski M, et al. Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO) Pediatr Res. 2000;48:679-84. Graulich J Walzog B Marcinkowski M et al Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO) Pediatr Res 200048679 8410.1203/00006450-200011000-0002111044491Search in Google Scholar

11Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801‐10. Singer M Deutschman CS Seymour CW et al The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016315801‐1010.1001/jama.2016.0287496857426903338Search in Google Scholar

12Beck L, Burg MC, Heindel W, Schülke C. Extracorporeal Membrane Oxygenation in Adults - Variants, Complications during Therapy, and the Role of Radiological Imaging. Rofo. 2017;189:119‐27. Beck L Burg MC Heindel W Schülke C Extracorporeal Membrane Oxygenation in Adults - Variants, Complications during Therapy, and the Role of Radiological Imaging Rofo 2017189119‐27Search in Google Scholar

13Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations. J Cardiothorac Vasc Anesth. 2010;24:164‐72. Sidebotham D McGeorge A McGuinness S Edwards M Willcox T Beca J Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations J Cardiothorac Vasc Anesth 201024164‐7210.1053/j.jvca.2009.08.00219875307Search in Google Scholar

14Moldoveanu B, Otmishi P, Jani P, et al. Inflammatory mechanisms in the lung. J Inflamm Res 2009;2:1‐11. Moldoveanu B Otmishi P Jani P et al Inflammatory mechanisms in the lung J Inflamm Res 20092 111Search in Google Scholar

15Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004;114:270-9 Hayashi T Beck L Rossetto C et al Inhibition of experimental asthma by indoleamine 2,3-dioxygenase J Clin Invest 2004114270 910.1172/JCI2127544974915254594Search in Google Scholar

16Raychaudhuri B, Fisher CJ, Farver CF, et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine. 2000;12:1348-55. Raychaudhuri B Fisher CJ Farver CF et al Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages Cytokine 2000121348 5510.1006/cyto.2000.072110975994Search in Google Scholar

17Pittet JF, Griffiths MJ, Geiser T, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-44. Pittet JF Griffiths MJ Geiser T et al TGF-beta is a critical mediator of acute lung injury J Clin Invest 20011071537 4410.1172/JCI1196320019211413161Search in Google Scholar